Literature DB >> 7157456

Phenytoin excretion in human breast milk and plasma levels in nursed infants.

B Steen, A Rane, G Lönnerholm, O Falk, C E Elwin, F Sjöqvist.   

Abstract

Phenytoin excretion into human breast milk was studied in six nursing women with epilepsy. The average ratio between the areas under the plasma (and milk) concentration versus time curves (AUC) was 0.13. There was a good (r = 0.97) correlation between the mean plasma and milk concentrations of phenytoin, and an even better relation (r = 0.99) between the AUC for phenytoin in plasma and the mean milk concentration. The ratio between unconjugated and conjugated 4-OH-phenytoin (the main metabolite) in plasma was 0.08-0.09. The corresponding ratio in milk was considerably higher. The present data do not argue against breast feeding during phenytoin therapy, not even when weighed against the potential risks for toxicity of the parent compound. Only two of six infants had a measurable, yet very low plasma concentration of phenytoin. The calculated body weight--related doses of phenytoin secreted into milk will be less than 5% of the dose to infants and small children.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7157456     DOI: 10.1097/00007691-198212000-00001

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  11 in total

Review 1.  Anticonvulsants and breast feeding: a critical review.

Authors:  B Bar-Oz; I Nulman; G Koren; S Ito
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 2.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

3.  Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity.

Authors:  Rika Hirashima; Hirofumi Michimae; Hiroaki Takemoto; Aya Sasaki; Yoshinori Kobayashi; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Mol Pharmacol       Date:  2016-07-13       Impact factor: 4.436

Review 4.  Anticonvulsant use during lactation.

Authors:  S Hägg; O Spigset
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Lactation studies of anticonvulsants: a quality review.

Authors:  Douwe H van der Meer; Andre Wieringa; Ilse Wegner; Bob Wilffert; Peter G J Ter Horst
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

Review 6.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; P B Pennell; B S Koppel; C A Hovinga; B Gidal; K J Meador; J Hopp; T Y Ting; W A Hauser; D Thurman; P W Kaplan; J N Robinson; J A French; S Wiebe; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; P O Shafer; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

7.  Amphetamine secretion in breast milk.

Authors:  E Steiner; T Villén; M Hallberg; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 8.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 9.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

10.  [Use of antiepileptic drugs during breastfeeding : What do we tell the mother?]

Authors:  M Crettenand; A O Rossetti; T Buclin; U Winterfeld
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.